Income Statement Shanghai Sanyou Medical Co., Ltd

Equities

688085

CNE1000040J7

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 08/05/2026			5-day change	1st Jan Change
19.34 ^CNY	+5.51%		+9.33%	+7.33%

04-27	Shanghai Sanyou Medical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-16	Zhuiyuan Medical Technology Co., Ltd. announced that it has received CNY 25 million in funding from Shanghai Sanyou Medical Co., Ltd, Shanghai Kinetic Medical Co., Ltd	CI

37aaf705b434.a6B591adEBneFuYFfxBQVr9j_nKnO0a8rAyf6ApMqf0.IcYdwTfKXXe2VYx3E2UTF9s7vz6ebnXq6EfwjlIFnNAz1h6kO_pSVa1cjQ

Published financial data: SHANGHAI SANYOU MEDICAL CO., LTD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	593M	648M	457M	452M	543M
Other Revenues, Total	413K	1.35M	3.48M	1.9M	-
Total Revenues	593M	649M	460M	454M	543M
Cost of Goods Sold, Total	63.61M	71.39M	104M	146M	136M
Gross Profit	530M	578M	357M	308M	407M
Selling General & Admin Expenses, Total	323M	334M	193M	212M	245M
Provision for Bad Debts	2.87M	2.79M	-8.76M	1.05M	-
R&D Expenses	56.55M	60.38M	65.22M	84.29M	83.71M
Other Operating Expenses	6.49M	7.68M	5.07M	4.46M	-2.95M
Other Operating Expenses, Total	389M	404M	255M	302M	326M
Operating Income	141M	173M	102M	6.14M	80.71M
Interest Expense, Total	-161K	-203K	-268K	-1.17M	-
Interest And Investment Income	34.3M	14.53M	16.25M	13.6M	-
Net Interest Expenses	34.14M	14.33M	15.99M	12.42M	-
Currency Exchange Gains (Loss)	-168K	97.08K	322K	-740K	-
Other Non Operating Income (Expenses)	186K	-200K	-307K	-1.43M	10.25M
EBT, Excl. Unusual Items	175M	188M	118M	16.39M	90.95M
Impairment of Goodwill	-	-	-	-72K	-
Gain (Loss) On Sale Of Investments	27.33M	36.32M	-6.89M	4.16M	-2.45M
Gain (Loss) On Sale Of Assets	-189K	-61.9K	-45.87K	6.42M	-69.04K
Asset Writedown	-	-	-	-10.13M	-33.23M
Other Unusual Items	15.33M	15.78M	24.22M	5.13M	-
EBT, Incl. Unusual Items	217M	240M	135M	21.9M	55.2M
Income Tax Expense	22.18M	35.99M	21.23M	9.79M	10.32M
Earnings From Continuing Operations	195M	204M	114M	12.11M	44.89M
Net Income to Company	195M	204M	114M	12.11M	44.89M
Minority Interest	-8.78M	-12.74M	-18.06M	-644K	18.21M
Net Income - (IS)	186M	191M	95.58M	11.47M	63.1M
Net Income to Common Incl Extra Items	186M	191M	95.58M	11.47M	63.1M
Net Income to Common Excl. Extra Items	186M	191M	95.58M	11.47M	63.1M
Per Share Items
Net EPS - Basic	0.63	0.64	0.32	0.04	0.19
Basic EPS - Continuing Operations	0.63	0.64	0.32	0.04	0.19
Basic Weighted Average Shares Outstanding	297M	300M	302M	275M	332M
Net EPS - Diluted	0.63	0.64	0.32	0.04	0.19
Diluted EPS - Continuing Operations	0.63	0.64	0.32	0.04	0.19
Diluted Weighted Average Shares Outstanding	297M	300M	302M	275M	332M
Normalized Basic EPS	0.34	0.35	0.18	0.03	0.23
Normalized Diluted EPS	0.34	0.35	0.18	0.03	0.23
Dividend Per Share	0.13	0.06	0.06	0	-
Payout Ratio	19.24	19.58	20.09	197.5	3.39
Supplemental Items
EBITDA	154M	187M	126M	36.41M	112M
EBITA	142M	175M	105M	14.77M	89.83M
EBIT	141M	173M	102M	6.14M	80.71M
EBITDAR	154M	188M	127M	37.31M	-
Total Revenues (As Reported)	593M	649M	460M	454M	-
Effective Tax Rate - (Ratio)	10.21	15.02	15.74	44.7	18.69
Total Current Taxes	26.35M	33.14M	6.94M	5.75M	-
Total Deferred Taxes	-4.17M	2.85M	14.29M	4.04M	-
Normalized Net Income	101M	104M	55.43M	9.6M	75.06M
Interest on Long-Term Debt	241K	203K	268K	-	-
Non-Cash Pension Expense	-	15K	38.5K	-	-
Supplemental Operating Expense Items
Marketing Expenses	13.55M	8.76M	6.66M	10.59M	-
Selling and Marketing Expenses	295M	297M	161M	145M	177M
General and Administrative Expenses	28.36M	36.68M	31.98M	67.16M	67.69M
Research And Development Expense From Footnotes	56.55M	60.38M	65.22M	84.29M	83.71M
Net Rental Expense, Total	595K	595K	566K	899K	-
Imputed Operating Lease Interest Expense	-	185K	234K	326K	-
Imputed Operating Lease Depreciation	-	410K	332K	573K	-
Stock-Based Comp., R&D Exp. (Total)	990K	766K	-	7.33M	-
Stock-Based Comp., S&M Exp. (Total)	1.12M	-	-	241K	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	196K	-
Total Stock-Based Compensation	2.11M	766K	-	7.76M	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	382M	340M	654M	403M	336M
Short Term Investments	-	-	-	235M	-
Trading Asset Securities, Total	377M	193M	19.63M	50.23M	241M
Total Cash And Short Term Investments	759M	534M	674M	688M	576M
Accounts Receivable, Total	253M	275M	61.53M	73.14M	96.73M
Other Receivables	2.4M	2.75M	940K	3.98M	1.78M
Total Receivables	255M	278M	62.46M	77.12M	98.51M
Inventory	121M	155M	177M	246M	283M
Other Current Assets, Total	14.91M	27.68M	33.19M	22.25M	221M
Total Current Assets	1.15B	994M	946M	1.03B	1.18B
Gross Property Plant And Equipment	321M	419M	441M	509M	-
Accumulated Depreciation	-64.5M	-73.21M	-96.75M	-163M	-
Net Property Plant And Equipment	256M	345M	344M	347M	338M
Long-term Investments	182M	425M	490M	426M	385M
Goodwill	315M	315M	315M	346M	346M
Other Intangibles, Total	32.81M	40.98M	85.59M	88.71M	96.87M
Deferred Tax Assets Long-Term	30.27M	33.65M	22.69M	3.8M	6.9M
Deferred Charges Long-Term	22.74M	26.17M	45.58M	32.49M	25.19M
Other Long-Term Assets, Total	6.87M	10.26M	11.88M	29.19M	793K
Total Assets	2B	2.19B	2.26B	2.31B	2.38B
Liabilities
Accounts Payable, Total	20.25M	28.06M	26.69M	58.44M	81.22M
Accrued Expenses, Total	123M	132M	77.67M	56.08M	31.48M
Short-term Borrowings	-	-	-	15.25M	19.96M
Current Portion of Long-Term Debt	-	-	-	8.5M	12.57M
Current Portion of Leases	2.59M	3.08M	4.15M	6.76M	-
Current Income Taxes Payable	13.67M	12.81M	1.09M	1.46M	14.07M
Unearned Revenue Current, Total	10.7M	9.73M	4.74M	6.23M	626K
Other Current Liabilities	65.13M	59.25M	80.1M	72.11M	68.42M
Total Current Liabilities	235M	245M	194M	225M	228M
Long-Term Debt	-	-	-	8.38M	2.03M
Long-Term Leases	2.49M	2.3M	834K	8M	6.87M
Unearned Revenue Non Current	6.83M	7.85M	6.69M	7.12M	6.21M
Pension & Other Post Retirement Benefits	-	-	-	1.64M	-
Deferred Tax Liability Non Current	4.1M	10.6M	16.11M	6.9M	5.86M
Other Non Current Liabilities	12.56M	12.56M	719K	1.04M	2.81M
Total Liabilities	261M	278M	219M	258M	252M
Common Stock, Total	205M	226M	248M	248M	333M
Additional Paid In Capital	1.05B	1.03B	1.01B	1.02B	1.07B
Retained Earnings	426M	579M	656M	648M	710M
Comprehensive Income and Other	-2.2K	40.68K	104K	-521K	-4.07M
Total Common Equity	1.69B	1.84B	1.92B	1.91B	2.1B
Minority Interest	50.42M	73.27M	127M	137M	20M
Total Equity	1.74B	1.91B	2.04B	2.05B	2.12B
Total Liabilities And Equity	2B	2.19B	2.26B	2.31B	2.38B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	298M	298M	298M	333M	350M
ECS Total Common Shares Outstanding	298M	298M	298M	298M	350M
Book Value / Share	5.65	6.17	6.43	6.41	6.02
Tangible Book Value	1.34B	1.48B	1.52B	1.48B	1.66B
Tangible Book Value Per Share	4.49	4.98	5.08	4.95	4.75
Total Debt	5.07M	5.39M	4.99M	46.9M	41.43M
Net Debt	-754M	-528M	-669M	-641M	-535M
Debt Equivalent Oper. Leases	4.76M	4.76M	4.53M	7.19M	-
Minority Interest, Total (Incl. Fin. Div)	50.42M	73.27M	127M	137M	20M
Equity Method Investments, Total	10.13M	32.02M	25.04M	13.3M	-
Account Code - Inventory Valuation	-	6	6	6	-
Inventories - Raw Materials, Total	26.94M	26.59M	33.9M	41.82M	-
Inventories - Work In Process, Total	22.12M	35.48M	49.67M	53.26M	-
Inventories - Finished Goods, Total	93.92M	120M	22.49M	34.32M	-
Inventories - Others	2.4M	371K	105M	163M	-
Buildings, Total	106M	246M	258M	257M	-
Machinery, Total	102M	137M	142M	185M	-
Full Time Employees	442	434	466	514	-
Accumulated Allowance for Doubtful Accounts (Supple)	14.43M	17.22M	8.47M	10.36M	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	186M	191M	95.58M	11.47M	44.89M
Depreciation & Amortization - CF	13.72M	15.82M	25.37M	28.28M	29.16M
Amortization of Goodwill and Intangible Assets - (CF)	1.77M	2.04M	3.26M	8.63M	9.12M
Depreciation & Amortization, Total	15.49M	17.86M	28.63M	36.91M	38.28M
Amortization of Deferred Charges, Total - (CF)	12.65M	16.36M	25.75M	24.51M	21.41M
(Gain) Loss From Sale Of Asset	-37.56K	61.9K	45.87K	-6.43M	69.04K
(Gain) Loss on Sale of Investments - (CF)	-26.44M	-46.76M	6.89M	-5.68M	3.55M
Asset Writedown & Restructuring Costs	-24.5M	2.9M	-	10.22M	32.14M
Provision for Credit Losses	7.23M	12.78M	-	-	-
Provision and Write-off of Bad Debts	-	-	-8.76M	1.05M	-
Other Operating Activities, Total	9.11M	12.83M	29.58M	18.56M	-463K
Change In Accounts Receivable	-70.1M	-39.32M	215M	2.06M	-12.91M
Change In Inventories	-40.6M	-55.03M	-73.57M	-68.15M	-61.1M
Change In Accounts Payable	75.88M	39.84M	-65.73M	-25.46M	-5.79M
Change In Deferred Taxes	-4.17M	2.85M	14.56M	4.04M	-4.14M
Change in Other Net Operating Assets	4.04M	774K	-232K	7.87M	12.05M
Cash from Operations	145M	156M	267M	10.96M	67.99M
Capital Expenditure	-91.66M	-138M	-25.94M	-37.44M	-28.91M
Sale of Property, Plant, and Equipment	371K	-	153K	5.42M	532K
Cash Acquisitions	-268M	-970K	-30.38M	-	-
Investment in Marketable and Equity Securities, Total	356M	-25.86M	124M	-204M	-131M
Other Investing Activities, Total	16.14M	8.88M	1.08M	2.76M	2.45M
Cash from Investing	12.36M	-156M	68.8M	-234M	-157M
Long-Term Debt Issued, Total	-	-	-	45.14M	19.71M
Total Debt Issued	-	-	-	45.14M	19.71M
Long-Term Debt Repaid, Total	-1.46M	-4.52M	-3.55M	-51.94M	-25.04M
Total Debt Repaid	-1.46M	-4.52M	-3.55M	-51.94M	-25.04M
Issuance of Common Stock	-	-	-	-	205M
Common Dividends Paid	-35.86M	-37.37M	-19.2M	-22.65M	-2.14M
Common & Preferred Stock Dividends Paid	-35.86M	-37.37M	-19.2M	-22.65M	-2.14M
Other Financing Activities, Total	-	-	-	1.28M	-179M
Cash from Financing	-37.32M	-41.9M	-22.75M	-28.17M	18.61M
Foreign Exchange Rate Adjustments	-104K	192K	444K	-469K	3.36M
Net Change in Cash	120M	-41.88M	314M	-251M	-67.44M
Supplemental Items
Cash Income Tax Paid (Refund)	69.84M	119M	71.76M	19.75M	41.83M
Levered Free Cash Flow	41.23M	-54.62M	229M	-34.28M	-174M
Unlevered Free Cash Flow	41.33M	-54.49M	229M	-33.55M	-174M
Change In Net Working Capital	-14.81M	59.58M	-137M	69.14M	255M
Net Debt Issued / Repaid	-1.46M	-4.52M	-3.55M	-6.8M	-5.33M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.8	5.17	2.85	0.17	2.15
Return on Total Capital	5.37	5.92	3.2	0.19	2.37
Return On Equity %	11.93	11.16	5.75	0.59	2.15
Return on Common Equity	11.57	10.82	5.09	0.6	3.14
Margin Analysis
Gross Profit Margin %	89.28	89	77.45	67.82	74.9
SG&A Margin	54.46	51.4	42.02	46.67	45.16
EBITDA Margin %	25.94	28.88	27.37	8.03	20.67
EBITA Margin %	24.01	27.01	22.77	3.26	16.55
EBIT Margin %	23.71	26.69	22.06	1.35	14.87
Income From Continuing Operations Margin %	32.89	31.36	24.68	2.67	8.27
Net Income Margin %	31.41	29.39	20.76	2.53	11.63
Net Avail. For Common Margin %	31.41	29.39	20.76	2.53	11.63
Normalized Net Income Margin	16.94	16.09	12.04	2.12	13.83
Levered Free Cash Flow Margin	6.95	-8.41	49.67	-7.56	-32.04
Unlevered Free Cash Flow Margin	6.97	-8.39	49.7	-7.4	-32.04
Asset Turnover
Asset Turnover	0.32	0.31	0.21	0.2	0.23
Fixed Assets Turnover	2.88	2.16	1.34	1.31	1.59
Receivables Turnover (Average Receivables)	2.64	2.45	2.71	6.71	6.39
Inventory Turnover (Average Inventory)	0.59	0.52	0.63	0.69	0.51
Short Term Liquidity
Current Ratio	4.9	4.06	4.87	4.6	5.16
Quick Ratio	4.32	3.31	3.79	3.4	2.95
Operating Cash Flow to Current Liabilities	0.62	0.64	1.38	0.05	0.3
Days Sales Outstanding (Average Receivables)	138.52	148.82	134.56	54.56	57.11
Days Outstanding Inventory (Average Inventory)	615.94	707.04	583.23	530.1	708.84
Average Days Payable Outstanding	170.92	83.97	79.68	72.32	147.28
Cash Conversion Cycle (Average Days)	583.54	771.89	638.11	512.33	618.67
Long Term Solvency
Total Debt/Equity	0.29	0.28	0.24	2.29	1.95
Total Debt / Total Capital	0.29	0.28	0.24	2.24	1.91
LT Debt/Equity	0.14	0.12	0.04	0.8	0.42
Long-Term Debt / Total Capital	0.14	0.12	0.04	0.78	0.41
Total Liabilities / Total Assets	13.06	12.7	9.67	11.18	10.61
EBIT / Interest Expense	875.37	854.25	378.9	5.23	-
EBITDA / Interest Expense	971.75	942.31	485.69	36.66	-
(EBITDA - Capex) / Interest Expense	401.51	261.02	388.94	4.78	-
Total Debt / EBITDA	0.03	0.03	0.04	1.09	0.37
Net Debt / EBITDA	-4.83	-2.76	-5.14	-14.89	-4.73
Total Debt / (EBITDA - Capex)	0.08	0.1	0.05	8.35	0.49
Net Debt / (EBITDA - Capex)	-11.68	-9.98	-6.42	-114.16	-6.35
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	51.97	9.4	-29.08	-1.48	19.66
Gross Profit, 1 Yr. Growth %	51.29	9.06	-38.28	-13.72	32.16
EBITDA, 1 Yr. Growth %	34.56	21.83	-33.21	-71.42	208.17
EBITA, 1 Yr. Growth %	35.04	23.05	-40.58	-86.1	508.13
EBIT, 1 Yr. Growth %	34.87	23.15	-41.38	-93.95	1.21K
Earnings From Cont. Operations, 1 Yr. Growth %	64.6	4.31	-44.17	-89.34	270.56
Net Income, 1 Yr. Growth %	57.2	2.39	-49.91	-88	450.2
Normalized Net Income, 1 Yr. Growth %	24.34	3.92	-46.93	-82.68	681.67
Diluted EPS Before Extra, 1 Yr. Growth %	44.43	1.21	-50.65	-86.83	355.64
Accounts Receivable, 1 Yr. Growth %	28.26	8.89	-77.66	18.88	32.25
Inventory, 1 Yr. Growth %	30.35	27.67	13.91	39.31	14.97
Net Property, Plant and Equip., 1 Yr. Growth %	64.41	34.77	-0.38	0.72	-2.55
Total Assets, 1 Yr. Growth %	19.54	9.72	3.2	2	3.05
Tangible Book Value, 1 Yr. Growth %	-11.44	10.89	2.14	-2.51	12.51
Common Equity, 1 Yr. Growth %	9.87	9.13	4.16	-0.23	10.09
Cash From Operations, 1 Yr. Growth %	86.94	7.63	71.46	-95.9	520.07
Capital Expenditures, 1 Yr. Growth %	201.01	50.77	-81.23	44.33	-22.77
Levered Free Cash Flow, 1 Yr. Growth %	-47.54	-232.47	-518.64	-114.99	407.21
Unlevered Free Cash Flow, 1 Yr. Growth %	-47.41	-231.84	-519.92	-114.66	418.3
Dividend Per Share, 1 Yr. Growth %	4.59	-48.64	0.93	-94.62	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	29.41	28.94	-11.91	-16.41	8.58
Gross Profit, 2 Yr. CAGR %	28.89	28.45	-17.96	-27.03	6.78
EBITDA, 2 Yr. CAGR %	18.74	28.04	-9.52	-56.07	-6.15
EBITA, 2 Yr. CAGR %	17.29	28.91	-14.22	-71.07	-8.05
EBIT, 2 Yr. CAGR %	17.06	28.87	-15.03	-81.17	-10.86
Earnings From Cont. Operations, 2 Yr. CAGR %	41.07	31.03	-23.69	-75.61	-37.15
Net Income, 2 Yr. CAGR %	38.03	26.87	-28.39	-75.48	-18.75
Normalized Net Income, 2 Yr. CAGR %	23.8	13.68	-25.74	-69.68	16.37
Diluted EPS Before Extra, 2 Yr. CAGR %	19.24	21.11	-29.03	-74.51	-22.54
Accounts Receivable, 2 Yr. CAGR %	22.37	18.18	-50.68	-48.46	25.39
Inventory, 2 Yr. CAGR %	33.48	29	20.59	25.97	26.56
Net Property, Plant and Equip., 2 Yr. CAGR %	34.99	48.85	15.87	0.17	-0.93
Total Assets, 2 Yr. CAGR %	90.3	14.53	6.41	2.6	2.52
Tangible Book Value, 2 Yr. CAGR %	79.56	-0.9	6.43	-0.21	4.73
Common Equity, 2 Yr. CAGR %	96.23	9.5	6.61	1.94	4.81
Cash From Operations, 2 Yr. CAGR %	53.23	41.85	35.84	-73.49	-49.58
Capital Expenditures, 2 Yr. CAGR %	7.25	113.03	-46.8	-47.95	5.58
Levered Free Cash Flow, 2 Yr. CAGR %	-32.35	-16.64	135.49	-20.77	-12.8
Unlevered Free Cash Flow, 2 Yr. CAGR %	-32.27	-16.73	135.29	-21.54	-12.83
Dividend Per Share, 2 Yr. CAGR %	-	-26.68	-28	-76.69	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	38.71	22.36	5.65	-8.56	-5.79
Gross Profit, 3 Yr. CAGR %	39.77	21.91	0.61	-16.57	-11.05
EBITDA, 3 Yr. CAGR %	32.12	19.76	3.28	-38.15	-15.9
EBITA, 3 Yr. CAGR %	32.12	19.18	-0.21	-53.02	-20.15
EBIT, 3 Yr. CAGR %	32.17	19.05	-0.89	-64.79	-22.48
Earnings From Cont. Operations, 3 Yr. CAGR %	46.58	27.56	-1.4	-60.41	-39.59
Net Income, 3 Yr. CAGR %	44.21	24.95	-6.93	-60.52	-30.85
Normalized Net Income, 3 Yr. CAGR %	35.06	16.78	-11.82	-54.28	-10.43
Diluted EPS Before Extra, 3 Yr. CAGR %	31.52	13.02	-9.96	-59.52	-33.35
Accounts Receivable, 3 Yr. CAGR %	34.92	17.7	-32.17	-33.87	-29.44
Inventory, 3 Yr. CAGR %	41.17	31.51	23.76	26.54	22.19
Net Property, Plant and Equip., 3 Yr. CAGR %	50.56	34.92	30.2	10.58	-0.75
Total Assets, 3 Yr. CAGR %	72.57	58.39	10.62	4.92	2.75
Tangible Book Value, 3 Yr. CAGR %	61.41	52.91	0.1	3.36	3.86
Common Equity, 3 Yr. CAGR %	70.45	61.37	7.69	4.28	4.59
Cash From Operations, 3 Yr. CAGR %	94.2	36.21	51.1	-57.71	-24.18
Capital Expenditures, 3 Yr. CAGR %	14.82	20.14	-5.21	-25.81	-40.64
Levered Free Cash Flow, 3 Yr. CAGR %	-15.16	-15.37	42.76	-5.97	47.11
Unlevered Free Cash Flow, 3 Yr. CAGR %	-15.09	-15.43	42.79	-6.72	47.22
Dividend Per Share, 3 Yr. CAGR %	-	-	-18.44	-69.67	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	35.91	15.67	5.06	6.81
Gross Profit, 5 Yr. CAGR %	-	40.46	12.94	-0.71	3.03
EBITDA, 5 Yr. CAGR %	-	79.8	13.55	-19.71	-0.38
EBITA, 5 Yr. CAGR %	-	100.4	11.16	-32.26	-3.17
EBIT, 5 Yr. CAGR %	-	104.49	10.76	-43.07	-5.01
Earnings From Cont. Operations, 5 Yr. CAGR %	-	112.58	12.89	-34.18	-17.66
Net Income, 5 Yr. CAGR %	-	105.54	8.99	-34.86	-11.85
Normalized Net Income, 5 Yr. CAGR %	-	83.51	6.33	-31.9	-1.47
Diluted EPS Before Extra, 5 Yr. CAGR %	-	87.45	2.83	-37.6	-15.22
Accounts Receivable, 5 Yr. CAGR %	-	42.06	-9.78	-15.41	-13.28
Inventory, 5 Yr. CAGR %	-	28.11	32.55	29.27	24.87
Net Property, Plant and Equip., 5 Yr. CAGR %	-	62.3	35.58	19.77	16.72
Total Assets, 5 Yr. CAGR %	-	45.52	42.23	33.13	7.31
Tangible Book Value, 5 Yr. CAGR %	-	41.02	36.64	28.91	1.93
Common Equity, 5 Yr. CAGR %	-	44.79	41.28	34.29	6.53
Cash From Operations, 5 Yr. CAGR %	-	48.58	68.33	-29.22	-2.59
Capital Expenditures, 5 Yr. CAGR %	-	30.42	-15.6	-14.02	-1.03
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	27.63	-17.57	17.21
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	27.65	-17.93	17.21
Dividend Per Share, 5 Yr. CAGR %	-	5.97	-	-	-